MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Long Term Provisions History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Long Term Provisions | ₹155 Cr | ₹123 Cr | ₹98 Cr | ₹80 Cr | ₹72 Cr |
What is the latest Long Term Provisions ratio of MANKIND PHARMA ?
Year | Long Term Provisions |
---|---|
Mar2025 | ₹155 Cr |
Mar2024 | ₹123 Cr |
Mar2023 | ₹98 Cr |
Mar2022 | ₹80 Cr |
Mar2021 | ₹72 Cr |
How is Long Term Provisions of MANKIND PHARMA Trending?
Years | Long Term Provisions | % Change | |
---|---|---|---|
Mar2025 | ₹155 Cr | 25.94 | |
Mar2024 | ₹123 Cr | 25.78 | |
Mar2023 | ₹98 Cr | 22.36 | |
Mar2022 | ₹80 Cr | 10.74 | |
Mar2021 | ₹72 Cr | - |
Compare Long Term Provisions of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹102,147.4 Cr | -4.9% | -2.6% | 6.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹380,594.0 Cr | -3.3% | -6.9% | -9.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,722.0 Cr | 1.7% | -6.8% | 25.4% | Stock Analytics | |
CIPLA | ₹127,508.0 Cr | -0.9% | 0.5% | -0.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,111.0 Cr | -1.9% | -1.3% | 7.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,225.0 Cr | -1.2% | -2% | -9% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | -4.9% |
-2.6% |
6.1% |
SENSEX | -2.2% |
-1.7% |
-1.2% |
You may also like the below Video Courses